Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-240
Closed 5553
2019
Q1
$0 Hold
240
﹤0.01% 5509
2018
Q4
$0 Buy
240
+96
+67% +$66 ﹤0.01% 5449
2018
Q3
$0 Hold
144
﹤0.01% 5403
2018
Q2
$0 Hold
144
﹤0.01% 5220
2018
Q1
$0 Sell
144
-88
-38% -$155 ﹤0.01% 5239
2017
Q4
$0 Sell
232
-242
-51% -$501 ﹤0.01% 5239
2017
Q3
$1K Hold
474
﹤0.01% 4804
2017
Q2
$1K Sell
474
-29
-6% -$99 ﹤0.01% 4755
2017
Q1
$1K Hold
503
﹤0.01% 4655
2016
Q4
$1K Hold
503
﹤0.01% 4471
2016
Q3
$1K Hold
503
﹤0.01% 4437
2016
Q2
$5K Buy
+503
New +$8.37K ﹤0.01% 3829

Other funds holding CYTR

Advisor Group's CYTR Position: Q2 2019 in Review

Advisor Group sold out of CytRx Corp (CYTR) in Q2 2019, closing a stake of 240 shares.

Advisor Group first reported a position in CYTR in Q2 2016 and held it in 12 quarters. The position peaked at $5K in Q2 2016. 5 funds tracked by Wall St. Rank hold CYTR as of Q2 2019.

  • Advisor Group reported no remaining CytRx Corp position as of Q2 2019 after selling out during the quarter.
  • Advisor Group sold 240 CytRx Corp shares in Q2 2019.
  • Advisor Group first reported a position in CytRx Corp in Q2 2016 and held it in 12 quarters.
  • Advisor Group's CytRx Corp position peaked at $5K in Q2 2016.
  • 5 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2019.

Based on Advisor Group's 13F filing for Q2 2019, filed 31 Jul 2019.